Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order

MMP9 / Gelatinase B

matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)

Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling.

Gene Name: matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
Family/Subfamily: Protease , Metallopeptidase M10A
Synonyms: MMP9, 92kd gelatinase, 92 kDa gelatinase, Matrix metalloproteinase-9, MMP-9, CLG4B, Gelatinase B, GELB, Macrophage gelatinase, MANDP2
Target Sequences: NM_004994 NP_004985.2 P14780

Publications (8)

1
B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ, Gerald D, Benjamin LE, Priolo C, Puxeddu E, Finn S, Jarzab B, Hodin RA, Pontecorvi A, Nose V, Lawler J, Parangi S. Proceedings of the National Academy of Sciences of the United States of America. 2010 107:10649-54. (IHC) [PubMed:20498063] [PMC:PMC2890809]
2
Is it really necessary to delay intranasal steroid treatment after FESS? An animal study. Bayraktar C, Atmaca S, Guvenc D, Karayigit MO, Atmaca E, Yarim M, Aksoy A. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2013 148:314-23. (IHC-P; Rabbit) [PubMed:23232827]
3
Tumor necrosis factor-like weak inducer of apoptosis or fn14 deficiency reduce elastase perfusion-induced aortic abdominal aneurysm in mice. Tarín C, Fernández-Laso V, Sastre C, Madrigal-Matute J, Gómez M, Zaragoza C, Egido J, Burkly LC, Martín-Ventura JL, Blanco-Colio LM. Journal of the American Heart Association. 2014 3: (IHC; Mouse) [Full Text Article] [PubMed:25092786] [PMC:PMC4310358] Related Antibodies: LS-B2486.
4
Aging alters the immunological response to ischemic stroke. Ritzel RM, Lai YJ, Crapser JD, Patel AR, Schrecengost A, Grenier JM, Mancini NS, Patrizz A, Jellison ER, Morales-Scheihing D, Venna VR, Kofler JK, Liu F, Verma R, McCullough LD. Acta neuropathologica. 2018 July;136:89-110. [Full Text Article] [PubMed:29752550] [PMC:PMC6015099]
5
Therapeutic Efficacy of Nanocomplex of Poly(Ethylene Glycol) and Catechin for Dry Eye Disease in a Mouse Model. Hyesook Lee, Whuisu Shim, Chae Eun Kim, So Yeon Choi, Haeshin Lee, Jaewook Yang. Investigative ophthalmology & visual science. 2017 March;58:1682-1691. [Full Text Article] [PubMed:28319642] Related Antibodies: LS-B2486.
6
Comparative Proteomic Analysis in Scar-Free Skin Regeneration in Acomys cahirinus and Scarring Mus musculus. Jung Hae Yoon, Kun Cho, Timothy J Garrett, Paul Finch, Malcolm Maden. Scientific reports. 2020 Jan;10:166. [Full Text Article] [PubMed:31932597] [PMC:PMC6957500] Related Antibodies: LS-B2486.
7
Telocytes are major constituents of the angiogenic apparatus. Soha A Soliman. Scientific reports. 2021 Mar;11:5775. [Full Text Article] [PubMed:33707590] [PMC:PMC7952407] Related Antibodies: LS-C31757.
8
Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma. Zhang W, Fulci G, Buhrman JS, Stemmer-Rachamimov AO, Chen JW, Wojtkiewicz GR, Weissleder R, Rabkin SD, Martuza RL. Molecular therapy : the journal of the American Society of Gene Therapy. 2012 Jan;20:37-45. [Full Text Article] [PubMed:21915104] [PMC:PMC3255598] Related Antibodies: LS-B2486.
more

☰ Filters
Products
Proteins (29)
Over-Expression Cell Culture Supernatant (1)
Over-Expression Lysate (3)
Recombinant (25)
MMP9 / Gelatinase B (29)
No (29)
10His, C-terminus (2)
6His, C-terminus (2)
6His, N-terminus (1)
GST (1)
His (8)
His, N-Terminal (5)
His, N-terminus (1)
His-S (1)
His-T7 (1)
Myc-DDK (Flag) (3)
Bovine (1)
Dog (1)
Human (15)
Mouse (6)
Rabbit (1)
Rat (4)
293T Cells (1)
E. coli (6)
Eukaryotic cells (2)
HEK 293 Cells (7)
Human Cells (6)
Mammalian Cells (2)
Wheat Germ Extract (1)
Yeast (4)
Purified (3)
Supernatant (1)
Low endotoxin level (11)
MMP9 / Gelatinase B Protein
Select
Yeast
6His, N-terminus
68.6 kD
100 µg/$446; 20 µg/$336; 1 mg/$1,460
MMP9 / Gelatinase B Protein - Eukaryotic Matrix Metalloproteinase 9 (MMP9) by SDS-PAGE
Select
Eukaryotic cells
His, N-Terminal
22kDa
10 µg/$291; 50 µg/$502; 200 µg/$1,002; 100 µg/$802; 1 mg/$2,144; 500 µg/$1,668; 5 mg/$3,501; 2 mg/$2,334
MMP9 / Gelatinase B Protein - Recombinant Matrix Metalloproteinase 9 By SDS-PAGE
Select
E. coli
His, N-terminus
22.2 kDa
10 µg/$287; 50 µg/$482; 100 µg/$770; 200 µg/$962; 1 mg/$2,094; 500 µg/$1,623; 5 mg/$3,361; 2 mg/$2,284
Select
Human Cells
10His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
80.2kD
10 µg/$321; 50 µg/$534; 500 µg/$1,585; 1 mg/$2,353
MMP9 / Gelatinase B Protein - Purified recombinant protein MMP9 was analyzed by SDS-PAGE gel and Coomassie Blue Staining
Select
HEK 293 Cells
Myc-DDK (Flag)
78.3 kDa
20 µg/$1,107
MMP9 / Gelatinase B Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
293T Cells
Myc-DDK (Flag)
78.3 kDa
20 µg/$150
MMP9 / Gelatinase B Protein
Select
HEK 293 Cells
His, N-Terminal
~78 kDa
10 µg/$289; 100 µg/$432; 250 µg/$726; 50 µg/$360
Select
HEK 293 Cells
His, N-Terminal
~78 kDa
200 µl/$283
Select
HEK 293 Cells
His, N-Terminal
~78 kDa
100 µg/$298
Select
Human Cells
None
Less than 1.0 EU/µg protein (determined by LAL method).
76.3 kDa
20 µg/$670; 100 µg/$1,374
Select
Human Cells
His
Less than 1.0 EU/µg protein (determined by LAL method).
77.7 kDa
20 µg/$515; 100 µg/$1,137
MMP9 / Gelatinase B Protein - Recombinant Matrix Metalloproteinase 9 By SDS-PAGE
Select
E. coli
His
19.7 kDa
10 µg/$294; 50 µg/$522; 100 µg/$832; 200 µg/$1,034; 1 mg/$2,192; 500 µg/$1,712; 5 mg/$3,641; 2 mg/$2,383
MMP9 / Gelatinase B Protein
Select
Yeast
His
19.6 kDa
10 µg/$307; 50 µg/$482; 100 µg/$722
MMP9 / Gelatinase B Protein - Recombinant  Matrix Metalloproteinase 9 By SDS-PAGE
Select
E. coli
His-S
22.04 kDa
10 µg/$289; 50 µg/$490; 100 µg/$782; 200 µg/$977; 1 mg/$2,114; 500 µg/$1,640; 5 mg/$3,417; 2 mg/$2,304
MMP9 / Gelatinase B Protein
Select
Yeast
His
68.32 kD
100 µg/$679; 20 µg/$429; 1 mg/$1,973
MMP9 / Gelatinase B Protein - 12.5% SDS-PAGE of human MMP9 stained with Coomassie Blue
Select
Wheat Germ Extract
GST
103.4 kDa
2 µg/$439
Select
Human Cells
6His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
77.4kD
10 µg/$321; 50 µg/$534; 500 µg/$1,585; 1 mg/$2,353
MMP9 / Gelatinase B Protein - Western validation with an anti-DDK antibody * L: Control HEK293 lysate R: Over-expression lysate
Select
HEK 293 Cells
Myc-DDK (Flag)
78.3 kDa
100 µg/$494
MMP9 / Gelatinase B Protein - hMMP-9 (~93 KD) was activated by 1 mM of p-Aminophenylmercuric acetate (APMA) at different time points at 37°C. After 24h of activation, the mature form hMMP-9 (~60 kD) could be readily observed. Samples at reducing condition were resolved in a SDS-PAGE. Protein per lane: 2.0 mg.
Select
HEK 293 Cells
None
Less than 1 EU/µg (determined by LAL method).
This 722 amino acid recombinant protein has a predicted molecular mass of approximately 80 kD. The protein migrates at about 92 kD in DTT-reducing conditions and about 92 kD in non-reducing condition by SDS-PAGE.The predicted N-terminal amino acid is Ala.
10 µg/$355; 25 µg/$497; 100 µg/$1,186
MMP9 / Gelatinase B Protein - Activity of activated human MMP-9 was measured by its ability to cleave the fluorogenic peptide Mca-PLGL-Dpa-AR-NH2B.
Select
HEK 293 Cells
None
Less than 1 EU/µg (determined by LAL method).
This 722 amino acid recombinant protein has a predicted molecular mass of approximately 80 kD. The protein migrates at about 92 kD in DTT-reducing conditions and 250 kD in non-reducing conditions by SDS-PAGE.The predicted N-terminal amino acid is Ala.
10 µg/$355; 25 µg/$497; 100 µg/$1,186
Select
Mammalian Cells
6His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
77.4 kDa
10 µg/$344; 50 µg/$584
Select
Mammalian Cells
10His, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
80.2 kDa
10 µg/$344; 50 µg/$584
MMP9 / Gelatinase B Protein - Eukaryotic Matrix Metalloproteinase 9 (MMP9) by SDS-PAGE
Select
Eukaryotic cells
His, N-Terminal
24kDa
10 µg/$287; 50 µg/$482; 200 µg/$962; 100 µg/$770; 1 mg/$2,094; 500 µg/$1,623; 5 mg/$3,361; 2 mg/$2,284
Select
E. coli
159 AA
His
Less than 0.1 EU/µg protein (determined by LAL method).
17.6 kDa
10 mg/$4,268; 5 mg/$3,201; 1 mg/$1,868; 0.5 mg/$1,475; 200 µg/$1,103; 100 µg/$756; 50 µg/$531
MMP9 / Gelatinase B Protein - Recombinant Matrix Metalloproteinase 9 By SDS-PAGE
Select
E. coli
His
19.9 kDa
10 µg/$285; 50 µg/$470; 100 µg/$750; 200 µg/$937; 1 mg/$2,063; 500 µg/$1,594; 5 mg/$3,277; 2 mg/$2,252
Viewing 1-25 of 29 product results


Filtered By:
Products: Proteins


If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.

PLEASE NOTE

For RESEARCH USE ONLY. Intended for use by laboratory professionals. Not intended for human diagnostic or therapeutic purposes.

The data on this page has been compiled from LifeSpan internal sources, the National Center for Biotechnology Information (NCBI), and The Universal Protein Resource (UniProt).